NCT05878860 - ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 22, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2029

Conditions

X-linked Retinoschisis

Interventions

BIOLOGICAL

ATSN-201

AAV.SPR-hGRK1-hRS1syn

Trial Locations (4)

RECRUITING

Children's Hospital of Philadelphia, Philadelphia

RECRUITING

Bascom Palmer Eye Institute, Miami

RECRUITING

Children's Hospital of Los Angeles, Los Angeles

RECRUITING

Oregon Health Sciences University, Portland